+216.9%
CLSK vs ALHC
+151.5%
+65.4%
-71.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALHC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.5% | -3.2% | +1.7% | -1.0% |
| 7D | +17.2% | -4.1% | +21.3% | +18.0% |
| 30D | +14.6% | -5.4% | +20.0% | +15.5% |
| 3M | -16.8% | -32.1% | +15.3% | -12.3% |
| 6M | +38.2% | -28.5% | +66.7% | +42.9% |
| YTD | +31.2% | -34.0% | +65.3% | +37.6% |
| 1Y | +37.3% | -20.9% | +58.3% | +39.6% |
| All | +216.9% | +151.5% | +65.4% | +95.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ALHC.
Daily Out/Under-Performance
Portfolio return minus ALHC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling